✦ LIBER ✦

Life table analysis of treatment episodes with disease-modifying anti-rheumatic drugs in rheumatoid arthritis

✍ Scribed by Nakazaki, Satoshi ;Murayama, Takashi ;Katoh, Siniti

Publisher: Informa UK (Informa Healthcare)
Year: 1999
Tongue: English
Weight: 474 KB
Volume: 9
Category: Article
ISSN: 0169-1163
DOI: 10.1007/bf03041273

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of previous gold treatment and

Influence of previous gold treatment and other patient variables on outcome of treatment with disease modifying anti-rheumatic drugs (DMARD) in patients with rheumatoid arthritis

✍ M. W. Bentzon; I. Gad; P. Halberg; O. Halskov; B. K. Jacobsen; I. Lorenzen; N. M 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 640 KB

Etanercept in combination with conventio

Etanercept in combination with conventional disease-modifying antirheumatic drugs (DMARDs) in the treatment of rheumatoid arthritis patients intolerant to methotrexate

✍ Yoshinobu Koyama; Hirokazu Shiraishi; Toshiyuki Ohta; Ayumi Uchino 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 350 KB

The importance of the disease process an

The importance of the disease process and disease-modifying antirheumatic drug treatment in the development of septic arthritis in patients with rheumatoid arthritis

✍ Edwards, Christopher J. ;Cooper, Cyrus ;Fisher, David ;Field, Max ;van Staa, Tje 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

Etanercept in the treatment of disease-m

Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials

✍ Masaaki Mori; Syuji Takei; Tomoyuki Imagawa; Hiroyuki Imanaka; Yasuhito Nerome; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 188 KB

Analysis of improvement in individual rh

Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo

✍ Harold E. Paulus; Marlene J. Egger; John R. Ward; H. James Williams 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

Five-year followup of rheumatoid arthrit

Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year

✍ Suzan M. M. Verstappen; Johannes W. G. Jacobs; Johannes W. J. Bijlsma; Anton H. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Objective To evaluate whether the clinical advantages observed after 1 year in a randomized controlled clinical trial, in which 2 treatment strategies were compared (the early disease‐modifying antirheumatic drug [DMARD] approach versus the pyramid approach), persist after 5 years.